Overview

In this episode of The Joe Rogan Experience, former Texas Governor Rick Perry and W. Bryan Hubbard, CEO of Americans for Ibogaine, announce a stunning breakthrough: the state of Texas has committed $100 million to fund the Texas Ibogaine Initiative, the largest psychedelic research and drug development project in U.S. history. The conversation moves between raw personal testimony—Perry's own brain scans showing a 27% increase in prefrontal cortex activity after ibogaine treatment—and a sweeping political strategy to force the federal government's hand by building a multi-state coalition that now includes Mississippi, Tennessee, Kentucky, West Virginia, and others. The episode feels like a war council and a revival meeting rolled into one, with Hubbard's soaring oratory and Perry's plainspoken gravitas making the case that ibogaine is not just a treatment for addiction but a tool for spiritual and national renewal.

0:34The Texas Breakthrough: From Skepticism to $100 Million

Hubbard opens by recounting the 15-month campaign that began after his first appearance on Rogan's show in December 2024. The initial plan was modest: organize 30 committed Texans whose families had been touched by trauma, addiction, or the wounds of war, and convince the state legislature to fund a $50 million public-private partnership for ibogaine drug development. What followed was a "five and a half month blistering campaign" to educate 188 Texas legislators. Hubbard set up shop in a Houston hotel, meeting with lawmakers continuously while his ally Logan Davidson of Texans for Greater Mental Health worked the halls. The result: 181 out of 188 legislators voted yes.

But the funding nearly collapsed at the 11th hour. On May 14, 2025, just 36 hours before the Texas budget was finalized, the money was not secured. Hubbard describes getting down on his knees in prayer, then receiving a call to meet with Texas House Speaker and Lieutenant Governor Dan Patrick. The key to unlocking Patrick's skepticism came from twin brothers Marcus and Morgan Luttrell—both former Navy SEALs with personal experience of ibogaine's life-saving effects. Marcus Luttrell, famously the sole survivor of Operation Red Wings, had lived with Perry at the Governor's Mansion for two and a half years while battling opioid addiction and suicidal ideation. The Luttrells spoke to Patrick "very movingly and personally" about what ibogaine had done for them and for fellow war fighters. That conversation turned the tide.

On May 16, 2025, at 10 a.m., Patrick confirmed he would approve and fully fund the initiative. But the scale had changed: instead of a $50 million public-private partnership, Texas decided to commit $100 million on its own, without any drug development partner, "for the good of humanity." Hubbard confirms this news just minutes before walking into Rogan's studio.

7:19What Ibogaine Is and What It Does

Rogan asks for a standalone explanation for newcomers. Hubbard provides a concise primer: ibogaine is an alkaloid derived from the iboga shrub, which originates in the Central Congo basin, with its native country being modern-day Gabon. The Bwiti spiritual tradition—encompassing Pygmy and Bantu tribes—has used it for centuries. In the early 1960s, researchers discovered that ibogaine had a "significant interruption effect" on opioid addiction. A heroin addict took ibogaine and experienced no withdrawal symptoms and lost all desire to use drugs. This touched off 60 years of open-label field studies.

The evidence now shows ibogaine can interrupt physiological substance dependency on opioids, alcohol, methamphetamine, cocaine, and tobacco. Recent evidence also suggests it affects compulsive behaviors like gambling. But the most striking development came in 2018, when U.S. Special Forces operators began traveling to Mexico for treatment of traumatic brain injury symptoms—treatment-resistant depression, anxiety, and suicidality. These veterans had been through the VA system, given "an unbelievable amount of synthetic pharmacology that essentially anesthetizes the soul and slowly euthanizes the body." Their recovery results seemed too good to be true.

Stanford University researchers, funded by philanthropists, studied what was happening. They discovered that ibogaine has "remarkable neuroregenerative capacities on the brain that are unheard of in the annals of western science." Preliminary evidence suggests benefits for multiple sclerosis, Lyme disease, Parkinson's disease, and post-surgical complications from brain tumor removal. Hubbard calls ibogaine "the most sophisticated molecule on the planet" for resolving physiological substance dependence and creating a psychological state where people "believe they have ownership of their selves and their future."

13:56Perry's Personal Journey: From "Lock Their Ass Up" to Johnny Appleseed of Ibogaine

Perry's involvement is the episode's emotional and political anchor. He describes growing up in the 1960s, absorbing the cultural message that psychedelics were dangerous—Timothy Leary, "just say no," "here's your brain on drugs." He went into the Air Force, took monthly drug tests. The idea of being involved with any drug was "totally and absolutely not on my radar screen."

His transformation began with criminal justice reform. A Democratic district judge in Fort Worth, John Crusoe, showed him a program that offered treatment instead of prison for drug offenders. Perry's initial reaction was "nope, I'm tough on crime. That's what us Republicans do." But he was curious. That single conversation led Texas to lead the nation in criminal justice reform, saving billions of dollars and stopping the construction of new prisons. Perry later took that template to Donald Trump in 2018, and with Brooke Rollins (then domestic policy advisor) making the pitch, Trump became open to federal criminal justice reform.

The ibogaine journey started with Marcus Luttrell. Perry met Luttrell in 2006 and told him, "If you're ever through Austin, come by and see me." In May 2007, Luttrell knocked on the guard door of the Governor's Mansion. Perry's wife, a nurse, recognized that this young man was "really troubled, addicted to opioids, masking it with alcohol, really sick." For the next two and a half years, Luttrell lived with them. They sent him to the Carrick Brain Center in Dallas, to a rehab facility in Florida—these helped him manage the addiction, but it was ibogaine treatment years later that "clean that completely away from him."

Perry's own experience with the compound came later. He had been severely concussed three times—twice in athletic events (knocked out completely for over a minute), once unloading horses. He developed mild anxiety and insomnia, masking them well enough that even his senior staff didn't know. In 2023, he followed the same protocol as the Stanford veteran study: baseline functional MRI, treatment at Ambio clinic south of Tijuana, then follow-up scans. The results were dramatic. One week after treatment, his prefrontal cortex showed a 27% increase in activity. At six months, his brain atrophy was gone. His neurosurgeon friend, Dr. Charlie Gordon, went from "respectful skeptic" to "full on believer," telling Perry, "Your brain looks like a 40-year-old."

Perry sums up his motivation: a friend of 30 years warned him not to throw away his reputation on "some cockamamie idea." Perry replied, "Their lives are not worth more than my reputation." He tells Rogan, "I'm 76 years old, and this is what I hope the Lord gives me a lot of years to make a difference."

30:15The Science of Neuroplasticity and the Critical Period

Hubbard brings in the work of Dr. Gul Dolen, an MD/PhD formerly at Johns Hopkins now at UC Berkeley, who spoke at South by Southwest about the concept of "critical periods" for different psychedelics. Ketamine opens a critical period of neuroplasticity for 48 to 72 hours. Psilocybin's window is 14 to 28 days. But ibogaine's critical period—the time when the brain can be trained, healed, and reset—is 90 to 120 days.

This extended window is what makes ibogaine uniquely powerful for addiction treatment. Perry cites the Stanford functional MRI data: an opioid-addicted brain treated with ibogaine shows a normal brain scan within 72 hours. By contrast, abstinence-based recovery takes 18 months, with single-digit success rates. With one dose, 85% of opioid addicts are clean in 72 hours. With two doses, the success rate reaches 98%. "There's nothing even remotely like it with standard practice addiction therapy," Hubbard says.

Perry adds a personal note about the power of opioids. During his 2011 presidential run, he had major back surgery in July and announced his candidacy in August. He was taking OxyContin for pain, Ambien to sleep, and Provigil to wake up focused. He jokes that he's surprised he did as well as he did in that campaign, given the cocktail of drugs in his system. "I'm surprised I could remember any of them," he says, referring to the famous debate moment when he forgot the third federal agency he wanted to eliminate.

37:02The Movement Spreads: State-by-State and Beyond

Americans for Ibogaine has grown from a six-person board—Perry as chairman, Hubbard as CEO, Dr. Rulin as secretary, Ann Claire Stapleton handling communications, and Marcus and Melanie Luttrell—into a national movement with ambassadors across the country. Hubbard describes the strategy: after Texas succeeded, they convened 200 people in Aspen, Colorado in November 2024, including invited, appointed, and elected state officials from 22 states. The goal is to create "an unstoppable external force through the states that can crash through the federal wall."

The roll call of states is impressive. Mississippi passed its ibogaine initiative with a $5 million appropriation from its opioid fund—the House voted 111-1, the Senate 51-1, and Governor Tate Reeves has signed it into law. West Virginia's House of Delegates voted 96-0, and the bill has been sent to the governor. Kentucky's Senate passed its bill 35-2, now awaiting House action. Tennessee's Senate Finance Committee voted 11-0 to move forward. Oklahoma's House has passed its bill. Louisiana has introduced Senate Bill 43. Missouri has two bills pending. Hubbard specifically calls out Missouri listeners to contact their legislature.

The American Legislative Exchange Council (ALEC), a center-right think tank that had historically taken only two positions on the war on drugs—"more prison, more penalties"—issued a formal position statement and model legislation endorsing the American Ibogaine Initiative after Perry and Hubbard spoke as keynote speakers on December 5, 2024.

International and tribal dimensions are also emerging. The government of Gabon has named Americans for Ibogaine as its official partner for advancing iboga medicine globally. Hubbard traveled there from January 6-20, 2025, describing it as "one of the most down home experiences" he's ever had. The Choctaw Nation will seek to join Texas in the drug development trial on their sovereign territory. On April 7, Hubbard will travel to Durant, Oklahoma for an inter-tribal council meeting of the Five Civilized Tribes—Choctaw, Chickasaw, Cherokee, Muscogee, and Seminole—expecting passage of a resolution declaring solidarity with the effort.

50:51Spiritual Famine and the Emancipation of the Soul

Hubbard's most extended argument is that the ibogaine movement is fundamentally a spiritual one. He describes a "profound spiritual famine in the United States," comparing it to the Ethiopian famine of the mid-1980s where "millions of people starved to death because the malevolence of power forbade the delivery of any relief." He argues that "the malevolence of American power is feasting on our starvation" and that this is "an emancipation movement for the mind, body, and soul of every human being in this country and across the globe who is lethally estranged from their own spirituality."

He connects this to the coming age of artificial intelligence and abundance. At the Earth One Summit, he heard visionaries like Kimbal and Christiana Musk speak about AI's capacity to solve the dilemma of scarcity. But Hubbard warns that you cannot deploy "godlike technology" with the capacity for unlimited abundance into "Frankenstein monstrosity government systems that are enthroned upon the helplessness of powerless people." Without a spiritual reawakening, the future "more resembles Mad Max than Star Trek."

The spiritual dimension also resonated with Texas legislators. Hubbard notes that "the most powerful aspect of the ibogaine argument" for many lawmakers was the experience, endorsed by many, that ibogaine "confirms without question the reality of our individual human divinity." He references a forthcoming book by Wendy Reese, A Christian's Guide to Psychedelics, written by a woman who was sexually assaulted by her father—a pastor—and found healing through ibogaine. Rogan adds the scholarly theory that Moses' burning bush was an acacia tree rich in DMT, and that the "sacred mushroom in the cross" theory from John Marco Allegro's decoding of the Dead Sea Scrolls suggests psychedelic use in ancient Christianity.

1:20:44Perry's Brain Scans and the Challenge to Rogan

Perry returns to his personal brain scan results as the centerpiece of his testimony. He describes the Stanford study of 30 veterans (ages 22-42) with moderate to severe PTSD and alcohol addiction. They received baseline functional MRIs, then traveled to Ambio for a four-day protocol: preparation on Tuesday, ibogaine Tuesday evening, recovery Wednesday, 5-MeO-DMT on Thursday, then home. Follow-up MRIs at five days, 30 days, and six months showed stunning results: 87% had zero PTSD at six months, with addiction reduction in the high 80th percentiles.

Perry followed the same protocol (minus the 5-MeO-DMT) despite having "as bucolic a life as you've ever had"—no trauma, a loving family, a dry land cotton farm upbringing. His baseline scan showed "pretty good" brain health for a 73-year-old with mild atrophy. One week after treatment: 27% increase in prefrontal cortex activity. Six months: his atrophy was gone. His neurosurgeon friend told him, "Your brain looks like a 40-year-old."

Then Perry turns the tables on Rogan. He asks how many times Rogan has been concussed—from sparring, from fights, from decades in martial arts. Rogan estimates "dozens." Perry asks directly: would Rogan be willing to be treated with ibogaine? Rogan answers without hesitation: "Yeah, I would definitely do it. I'm very fascinated by it. I've never heard anybody say I wish I didn't do it."

1:41:03The Federal Wall and the Path Forward

The conversation turns to the obstacles at the federal level. Hubbard acknowledges that well-intentioned reformers within the current administration—Secretary Kennedy, Secretary Collins—have voiced support for plant medicine but are "stymied by two realities": the byzantine complexity of federal bureaucracy captured by companies that profit from keeping problems alive, and political cross-currents within the administration that view psychedelics with indiscriminate skepticism.

The key legal mechanism is the federal Right to Try law, authored by former Senator Kyrsten Sinema and signed by President Trump in 2018. This law provides that once any medication completes Phase 1 safety testing within the FDA process, anyone with a life-threatening condition for which that medication is being developed can request treatment from a willing prescriber. The implication is enormous: as soon as Texas or a Native tribe completes a Phase 1 safety study on ibogaine, anyone with opioid dependency could legally access treatment.

But the DEA has asserted that Right to Try does not apply to Schedule 1 substances. When Sinema explained that the law's language is unambiguous—it says "any medication"—the DEA's response was "insolence and a refusal to honor what the statute actually says." Hubbard calls this "the use of fictitious legal realities to do violence to legitimate reality."

Perry adds that "the easiest and safest answer for a bureaucrat is no," and expresses hope that they can sit down with President Trump to discuss rescheduling ibogaine from Schedule 1 to Schedule 2 or 3. "There's no reason in the world that ibogaine is on Schedule 1," Perry argues. "It does have medical purposes, and it is non-addictive."

2:06:33The Kentucky Story: Tamara and Andy Beshear

Hubbard tells a devastating story from his time running Kentucky's Opioid Abatement Commission. Before designing the program, he held 20 town halls across the state. What began as technocratic presentations turned into "mass catharsis events" where thousands poured out their grief. The consistent response: "We don't think you have the competence or the integrity to do anything that's going to make a meaningful difference."

At one town hall, a volunteer told the story of Tamara. At age 10, Tamara had been horrifically sexually abused by a family member, requiring reconstructive surgeries. A volunteer worked with her for two to three years, then lost contact, assuming she had recovered. Ten years later, that same volunteer was teaching yoga at the Perry County detention center in Hazard, Kentucky. She saw a withdrawn young woman in the corner—Tamara. The opioids she was given for her surgical pain became the way she treated her "tremendous spiritual and emotional pain." She was arrested for possession of OxyContin and put in jail.

"The response of power to her was a prison," Hubbard says. "This is why what we're doing is so necessary."

Hubbard then launches into a blistering attack on Kentucky Governor Andy Beshear, whom he accuses of blocking the ibogaine initiative. He claims Beshear and his father, former Governor Steve Beshear, were law partners at the firm that represented Purdue Pharma against the people of Kentucky in OxyContin litigation. Hubbard alleges that the firm's malpractice resulted in a $24 million settlement instead of the $1 billion Kentucky should have received, and that 17 million documents were destroyed as part of the settlement. He calls Beshear a "performative public piety purveyor" and says, "If he were actually going to preach the part of the Bible that he has lived, he would talk more about Judas and the 40 pieces of silver."

2:17:42The Bicentennial Children's Reckoning

Hubbard closes with a sweeping historical meditation. He identifies himself and his generation—Generation X, the "bicentennial children"—as the grandchildren of the Greatest Generation that "overcame the Great Depression, defeated Nazism, killed Jim Crow, and crushed totalitarian communism." Over the past 50 years, his generation has experienced "the mass extinction of family and community," becoming "the first generational cohort of mass refugees from obliterated biological families."

He catalogs the failures: the opioid epidemic ("the gravest engineered humanitarian catastrophe to play out within our borders since the end of the 19th century"), the 2008 financial crisis that "forcibly dispossessed millions of us from the American dream, including 52% of African American homeowners," and "25 years of unremittent warfare" that has taken more service member lives by suicide than in battle. Over the last 10 years, 1.5 million Americans have died from drug overdose, alcohol-related disease, and suicide—"a figure that exceeds the total number of war casualties going all the way back to 1776."

He cites statistics: 102 U.S. counties with life expectancies lower than North Korea's; only 18% of Americans believe the federal government can do the right thing; 80% say the American dream is dead. "Power has answered these unconscionable realities with a maelstrom of bureaucratic absurdity, impudent incompetence, and predatory corruption."

But he ends on a note of defiant hope. "We are desperate and we are determined. And we will crawl the last mile to deliver good tidings unto the meek. To bind up the brokenhearted. To proclaim liberty to the captives." He calls Rogan "the Walter Cronkite of our age" and thanks him for the platform.

Conclusion

What stays with the listener is the convergence of unlikely forces: a conservative former governor who risked his reputation, a hillbilly lawyer turned orator, Navy SEAL twins, and a comedian with a podcast, all pushing in the same direction. The episode matters because it documents a genuine political breakthrough—$100 million from Texas, unanimous votes in West Virginia, near-unanimous votes in Mississippi—and because it makes the case that ibogaine is not just another drug but potentially the most important therapeutic discovery of the century. The spiritual framing, which could feel forced, lands because it's grounded in specific, verifiable outcomes: brain scans, recovery rates, saved lives. The episode is a status report on a movement that believes it is winning.

Key takeaways

• Texas has committed $100 million to fund the Texas Ibogaine Initiative, the largest psychedelic research project in U.S. history, after a campaign that secured 181 of 188 legislative votes.
• Ibogaine shows an 85% success rate for opioid addiction cessation after one dose and 98% after two doses, with brain scans normalizing within 72 hours compared to 18 months for abstinence-based recovery.
• Stanford research has demonstrated ibogaine's neuroregenerative properties, including a 27% increase in prefrontal cortex activity one week after treatment and reversal of brain atrophy.
• Rick Perry personally underwent ibogaine treatment and his six-month brain scan showed his atrophy was gone, with his neurosurgeon describing his brain as looking "like a 40-year-old."
• At least seven states (Texas, Mississippi, West Virginia, Kentucky, Tennessee, Oklahoma, Louisiana) have passed or are advancing ibogaine legislation, with Mississippi's House voting 111-1 and West Virginia's 96-0.
• The federal Right to Try law could allow immediate access to ibogaine after Phase 1 safety trials, but the DEA has blocked this by asserting the law doesn't apply to Schedule 1 substances.
• The government of Gabon has named Americans for Ibogaine as its official partner, and the Choctaw Nation and four other major tribes are expected to join the initiative.
• Hubbard argues that the ibogaine movement is fundamentally a spiritual emancipation effort, necessary to create social cohesion before the coming age of AI-driven abundance.